MCHP MICROCHIP TECHNOLOGY INC
Semiconductors & Related Devices · Nasdaq · SEC CIK 827054 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY33.0%
TTM net income YoY552.8%
TTM EPS YoY395.6%
Revenue 3-yr CAGR-14.4%
Net income 3-yr CAGR-30.7%
Margins
Gross margin62.7%
Operating margin20.9%
Net margin15.0%
FCF margin26.0%
EBITDA margin28.1%
Returns
ROE12.6%
ROA5.8%
ROIC (approx.)8.6%
Asset turnover0.38x
Leverage & solvency
Liabilities / assets54.7%
Debt / equity0.83x
Current ratio2.24x
Interest coverage5.75x
Cash quality & payout
Operating cash flow / net income1.82x
Accruals ratio-4.7%
Payout ratio117.8%
Capex / revenue1.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q22026-09-30 | 2027Q12026-06-30 | 2026Q4*2026-03-31 | 2026Q32025-12-31 | 2026Q22025-09-30 | 2026Q12025-06-30 | 2025Q4*2025-03-31 | 2025Q32024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.62B | $1.48B | $1.31B | $1.19B | $1.14B | $1.08B | $970.50M | $1.03B |
| Cost of revenue | $553.50M | $545.80M | $511.60M | $479.10M | $502.50M | $498.80M | $469.40M | $464.60M |
| Gross profit | $1.07B | $938.90M | $799.60M | $706.90M | $637.90M | $576.70M | $501.10M | $561.40M |
| R&D expense | $318.50M | $308.90M | $293.80M | $274.30M | $262.30M | $255.50M | $255.20M | $246.20M |
| SG&A expense | $186.90M | $184.30M | $174.20M | $168.50M | $172.30M | $159.30M | $152.00M | $158.20M |
| Operating income | $464.50M | $336.80M | $217.40M | $151.70M | $88.90M | $32.10M | -$100.30M | $30.90M |
| Interest expense | $47.30M | $48.80M | $51.70M | $55.90M | $56.30M | $57.40M | $69.60M | $68.70M |
| Pretax income | $417.50M | $289.90M | $163.90M | $93.60M | $31.80M | -$15.80M | -$168.30M | -$46.10M |
| Income tax | $16.10M | $60.10M | $19.70M | $30.90M | -$9.90M | $2.80M | -$13.70M | $7.50M |
| Net income | $401.40M | $229.80M | $144.20M | $62.70M | $41.70M | -$18.60M | -$154.60M | -$53.60M |
| EBITDA | $500.50M | $493.50M | $391.10M | $189.50M | $127.90M | $203.20M | $86.70M | $71.30M |
| EPS (basic) | 0.69 | 0.37 | — | 0.06 | 0.03 | -0.09 | — | -0.10 |
| EPS (diluted) | 0.68 | 0.37 | — | 0.06 | 0.03 | -0.09 | — | -0.10 |
| Dividends declared per share | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 |
| Weighted avg. shares (diluted) | 550.60M | 550.50M | — | 545.50M | 545.00M | 539.20M | — | 537.40M |
| Balance sheet | ||||||||
| Cash & equivalents | $457.00M | $272.30M | $240.30M | $250.70M | $236.80M | $566.50M | $771.70M | $586.00M |
| Receivables | $963.10M | $967.70M | $894.70M | $731.20M | $746.20M | $765.50M | $689.70M | $857.20M |
| Inventory | $1.12B | $1.05B | $1.04B | $1.06B | $1.10B | $1.17B | $1.29B | $1.36B |
| Current assets | $2.75B | $2.49B | $2.38B | $2.29B | $2.35B | $2.75B | $2.99B | $3.00B |
| PP&E, net | $1.07B | $1.08B | $1.11B | $1.13B | $1.15B | $1.15B | $1.18B | $1.15B |
| Goodwill | $6.70B | $6.70B | $6.70B | $6.70B | $6.70B | $6.70B | $6.68B | $6.68B |
| Intangibles | $1.92B | $2.00B | $2.03B | $2.10B | $2.17B | $2.29B | $2.39B | $2.52B |
| Total assets | $14.66B | $14.41B | $14.37B | $14.33B | $14.47B | $14.98B | $15.37B | $15.63B |
| Current liabilities | $1.22B | $1.29B | $1.14B | $1.06B | $1.04B | $1.19B | $1.16B | $1.33B |
| Short-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term debt | $5.52B | $5.36B | $5.50B | $5.37B | $5.38B | $5.46B | $5.63B | $6.75B |
| Total debt | $5.52B | $5.36B | $5.50B | $5.37B | $5.38B | $5.46B | $5.63B | $6.75B |
| Total liabilities | $8.02B | $7.96B | $7.94B | $7.77B | $7.77B | $8.12B | $8.30B | $9.60B |
| Shareholders' equity | $6.64B | $6.45B | $6.43B | $6.56B | $6.70B | $6.86B | $7.08B | $6.03B |
| Net debt | $5.06B | $5.09B | $5.26B | $5.12B | $5.14B | $4.89B | $4.86B | $6.16B |
| Shares outstanding | 544.22M | 543.01M | 542.08M | 541.13M | 540.45M | 539.68M | 538.70M | 537.76M |
| Cash flow statement | ||||||||
| Operating cash flow | $419.20M | $511.50M | $257.00M | $341.40M | $88.10M | $275.60M | $205.90M | $271.50M |
| Capital expenditure | $23.10M | $13.90M | $14.20M | $22.50M | $36.50M | $17.90M | $14.20M | $18.10M |
| Free cash flow | $396.10M | $497.60M | $242.80M | $318.90M | $51.60M | $257.70M | $191.70M | $253.40M |
| Investing cash flow | -$99.50M | -$52.00M | -$52.10M | -$44.50M | -$62.00M | -$36.90M | -$56.00M | -$42.10M |
| Financing cash flow | -$135.00M | -$427.50M | -$215.30M | -$283.00M | -$355.80M | -$443.90M | $35.80M | $70.50M |
| Depreciation & amortization | $36.00M | $156.70M | $173.70M | $37.80M | $39.00M | $171.10M | $187.00M | $40.40M |
| Stock-based compensation | $72.00M | $75.00M | $68.30M | $72.60M | $61.60M | $52.90M | $40.70M | $49.40M |
| Dividends paid | $247.60M | $246.90M | $246.60M | $246.10M | $245.80M | $245.50M | $244.80M | $244.60M |
| Share buybacks | — | — | $0 | $0 | $0 | $0 | $0 | $6.50M |
Free plan shows the latest 8 periods; Pro shows all 74 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.